Latest news and blogs
Monday 16 November 2015
With the deadline for this year’s 3Rs Prize nominations approaching, we got in touch with 2014 winner, Dr Oliver Britton from University of Oxford, to discuss his experience of the process, winning and his year since. Dr Britton was the first PhD student to win the prize, for his work under the supervision of...
Tuesday 10 November 2015
Today sees the publication of a roadmap on non-animal technologies (NATs) which has been jointly developed by six organisations – Innovate UK, the NC3Rs, BBSRC, EPSRC, MRC and Dstl. Here Dr Vicky Robinson the NC3Rs Chief Executive describes the background to the roadmap.
Tuesday 10 November 2015
The NC3Rs in partnership with five other organisations – Innovate UK, the BBSRC, EPSRC, MRC, and Dstl – has published a roadmap on developing and applying non-animal technologies (NATs) to improve the methods and tools available for the safety and efficacy testing of pharmaceuticals, veterinary products,...
Thursday 05 November 2015
The NC3Rs is pleased to announce the appointment of five new Board members.
Wednesday 21 October 2015
A project funded through the NC3Rs/Innovate UK Non-Animal Technologies (NATs) programme has claimed a breakthrough by creating a 3D printer capable of working with delicate induced pluripotent stem (iPS) cells.
Monday 19 October 2015
We are pleased to announce the award of three grants under our joint strategic award competition with the BBSRC in the area of replacing animal models of bovine Tuberculosis (bTB). The current UK bovine tuberculosis epidemic is one of the biggest challenges facing cattle farming in the UK with very serious...
Friday 16 October 2015
In 2014 the NC3Rs launched a programme of work to support the wide-scale development and application of pathways-based approaches, with the aim of improving the science of human and environmental safety assessment and ultimately reducing the reliance on animal toxicity testing.
New CRACK IT Solution: Comprehensive target screening by label-free cell microarray profiling to reduce animal efficacy and toxicology studies in drug discovery
Thursday 15 October 2015
There is an unmet need for a solution that can provide comprehensive target information at the lead selection stage of small molecule drug discovery. Interactions with proteins beyond the intended target influence the therapeutic, ADME and toxicity profile of small molecule drugs. Many off-target interactions...
Wednesday 14 October 2015
New work published in PLOS Biology by Professor Malcolm Macleod and Dr Emily Sena from the CAMARADES group at the University of Edinburgh shows continuing problems with the quality of animal research, based on information included in papers on the use of approaches to minimise subjective bias. The study...
Tuesday 13 October 2015
The NC3Rs has been announced as a consortium partner for a new collaborative project awarded under the Horizon 2020 framework, in which academia will work alongside small and medium-sized enterprises (SMEs), large industry, contract research organisations (CROs) and regulatory bodies to achieve more efficient...